These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Compensatory changes of sympathetic tone, the renin-angiotensin-aldosterone system, vasopressin, and ANF as potential therapeutic targets in congestive heart failure. van Zwieten PA Z Kardiol; 1988; 77 Suppl 5():67-76. PubMed ID: 2975894 [TBL] [Abstract][Full Text] [Related]
11. Recognized molecular mechanisms of heart failure: approaches to treatment. Ceconi C; Cargnoni A; Curello S; Ferrari R Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784 [TBL] [Abstract][Full Text] [Related]
15. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247 [TBL] [Abstract][Full Text] [Related]
16. Cardiac afferents and neurohormonal activation in congestive heart failure. Davila DF; Donis JH; Bellabarba G; Torres A; Casado J; Mazzei de Davila C Med Hypotheses; 2000 Feb; 54(2):242-53. PubMed ID: 10790760 [TBL] [Abstract][Full Text] [Related]
17. [Activation of the renin-angiotensin-aldosterone system in heart failure]. Volpe M; Tocci G; Pagannone E Ital Heart J; 2005 May; 6 Suppl 1():16S-23S. PubMed ID: 15945296 [TBL] [Abstract][Full Text] [Related]